These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21640931)

  • 1. Coronary stenting with MGuard: extended follow-up of first human trial.
    Grube E; Hauptmann KE; Müller R; Uriel N; Kaluski E
    Cardiovasc Revasc Med; 2011; 12(3):138-146. PubMed ID: 21640931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary stenting with MGuard: first-in-man trial.
    Kaluski E; Hauptmann KE; Müller R; Tsai S; Klapholz M; Grube E
    J Invasive Cardiol; 2008 Oct; 20(10):511-5. PubMed ID: 18829994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization.
    Maia F; Costa JR; Abizaid A; Feres F; Costa R; Staico R; Siqueira D; Esteves V; Sousa A; Sousa JE
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):86-92. PubMed ID: 20578092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
    JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year results of the INSPIRE trial with the novel MGuard stent: serial analysis with QCA and IVUS.
    Costa JR; Abizaid A; Feres F; Costa R; Staico R; Siqueira D; Centemero M; Tanajura LF; Sousa A; Sousa JE
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1095-100. PubMed ID: 21786400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
    Vaknin-Assa H; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1055-7. PubMed ID: 19434749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
    Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE;
    Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.
    Cassese S; Esposito G; Mauro C; Varbella F; Carraturo A; Montinaro A; Cirillo P; Galasso G; Rapacciuolo A; Piscione F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1118-26. PubMed ID: 22105879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
    Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I; Samuel J; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(2):103-9. PubMed ID: 19327672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.